Trees Corporation CANN OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score

29/100

1/5 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Trees Corporation (CANN) .

本页证实的标准:

VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。

SharesGrow 综合评分： 28/100 其中 1/7 项标准通过。

SharesGrow 7-Criteria Score

29/100

SG Score

View full scorecard →

—

价值

N/A

No coverage

—

未來

N/A

No coverage

✗

过去

0/100

→ Income

✗

健康

0/100

Debt-to-Equity & liquidity

→ Health

✗

护城河

36/100

→ Income

✓

成长

100/100

→ Income

✗

收入

10/100

→ Income

估值概览 — CANN

估值倍数

P/E (TTM)0.0

前瞻 P/EN/A

PEG 比率N/A

前瞻 PEGN/A

P/B 比率0.00

P/S 比率0.22

EV/EBITDA0.0

每股数据

EPS (TTM)$-0.03

每股账面价值$0.00

每股营收$0.13

每股自由现金流$0.00

收益率与内在价值

盈利收益率N/A

股息收益率0.00%

EPS：实际 vs 预期

P/E Ratio & Earnings Yield

每股收益 (EPS) 历史

Year	EPS（稀释）	营收	净利润	净利润率
2015	$-0.63	$1.76M	$-8.79M	-498.4%
2016	$-2.12	$2.98M	$-32.8M	-1099.9%
2017	$-0.40	$3.52M	$-8.22M	-233.4%
2018	$-0.49	$4.62M	$-16.97M	-367.5%
2019	$-0.39	$3.67M	$-14.83M	-404.4%
2020	$-0.17	$7.12M	$-8.53M	-119.8%
2021	$-0.15	$5.93M	$-10.31M	-174%
2022	$-0.07	$13.44M	$-9.48M	-70.5%
2023	$-0.06	$18.14M	$-7.08M	-39%
2024	$-0.03	$13.66M	$-3.48M	-25.5%